Company Overview
About Jenavalve
JenaValve is a medical device company based in the United States that is redefining the treatment of severe aortic regurgitation. The company has developed the Trilogy System, a dedicated TAVR solution for patients with this condition, and is conducting clinical trials to evaluate its safety and efficacy.
Technologies Used
Key Decision Makers
| Name | Job Title | Contact | |
|---|---|---|---|
Mark Meyers | Clinical Trial Lead | LinkedIn Profile | |
Steve Shin | Clinical Trial Lead | LinkedIn Profile | |
Gigi Lopez | Clinical Research Associate | LinkedIn Profile |